Showing 1489 results
-
Press release /Sandoz investment expected to be at least USD 400m – MOU signed today in Ljubljana at ceremony led by Slovenian Prime Minister and Sandoz CEO New project underpins Sandoz ambition to drive…
-
Press release /Biosimilar Hyrimoz® (adalimumab-adaz) high-concentration formulation (HCF) approved for seven indications of reference medicine Humira®* With this approval, Sandoz adalimumab HCF biosimilar will…
-
Pulse Update /
-
Media Library / -
Media Library / -
Media Library / -
Press release /Submission supported by comprehensive analytical and clinical data package Denosumab indicated for treating variety of conditions including osteoporosis in postmenopausal women1,2 Sandoz…
-
Story /Novartis drug hunters leverage machine learning and automation to power a faster, smarter way to navigate to new drugs.
-
Story /Novartis is investing in a novel type of medicine to reduce the risk of heart disease.